As shown in Figure 1d, the addition of birinapant indeed led to a further enhancement of both TRAIL/zVAD/CHX- and TNF/zVAD/CHX-induced programmed necrosis in all sensitive tumor cell lines, but not in the resistant tumor cell line KNS-62. The gene discussed is TNF; the disease is neoplasm.